Observational study / 2014
A case report describes thyrotoxic periodic paralysis and severe hypokalemia linked to a weight-loss nutraceutical containing triiodothyronine (T3).
A 24-year-old healthy manual laborer developed quadriparesis during rest following heavy exertion and carbohydrate intake. He presented with severe hypokalemia (potassium level 1.9 mmole/L) without evidence of renal or gastrointestinal potassium wasting. Laboratory studies confirmed factitious T3 toxicosis after he reported consuming nutraceuticals containing T3 for 1 month for weight loss. Correcting the hypokalemia reversed the paralysis, and avoiding further T3 intake prevented recurrence.
Shows an association, not proof of cause and effect.
- Study type
- Case report
- Who was studied
- A 24-year-old male manual laborer
- What was measured
- Quadriparesis, hypokalemia, and thyrotoxic periodic paralysis following nutraceutical intake
THE PAPER
I lost weight, but I became weak and cannot walk--a case of nutraceutical (T3)-induced thyrotoxic periodic paralysis.
Panikkath R, Nugent K. Am J Ther, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.